The evidence for beta blockers in heart failure.
作者信息
Cleland J G, McGowan J, Clark A, Freemantle N
出版信息
BMJ. 1999 Mar 27;318(7187):824-5. doi: 10.1136/bmj.318.7187.824.
Abstract
摘要
相似文献
1
The evidence for beta blockers in heart failure.β受体阻滞剂用于心力衰竭的证据。
BMJ. 1999 Mar 27;318(7187):824-5. doi: 10.1136/bmj.318.7187.824.
2
Beta-blockers in heart failure.
Lancet. 1999 Mar 20;353(9157):1011-2. doi: 10.1016/S0140-6736(99)00050-1.
3
Conclusions on the management of heart failure.关于心力衰竭管理的结论。
J Renin Angiotensin Aldosterone Syst. 2004 Sep;5 Suppl 1:S34-6. doi: 10.3317/jraas.2004.023.
4
Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? Aldosterone receptor antagonists?使用血管紧张素转换酶抑制剂和β受体阻滞剂治疗心力衰竭：下一步是什么？醛固酮受体拮抗剂？
Clin Res Cardiol. 2007 Apr;96(4):193-5. doi: 10.1007/s00392-007-0487-y. Epub 2007 Feb 15.
5
Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? AT1-receptor antagonists?使用血管紧张素转换酶抑制剂和β受体阻滞剂治疗心力衰竭：下一步是什么？血管紧张素Ⅱ1型受体拮抗剂？
Clin Res Cardiol. 2007 Apr;96(4):196-8. doi: 10.1007/s00392-007-0488-x. Epub 2007 Feb 15.
6
Survival of rats with experimental chronic heart failure depending on pharmacodynamic and pharmacokinetic parameters of angiotensin-converting enzyme inhibitors and beta-adrenoceptor blockers.
Bull Exp Biol Med. 2006 Jan;141(1):40-3. doi: 10.1007/s10517-006-0088-1.
7
Cellular basis for therapeutic choices in heart failure.心力衰竭治疗选择的细胞基础。
Circulation. 2004 Oct 26;110(17):2559-61. doi: 10.1161/01.CIR.0000146803.14063.F7.
8
15 years of heart-failure trials: what have we learned?
Lancet. 1998 Aug;352 Suppl 1:SI29-33. doi: 10.1016/s0140-6736(98)90016-2.
9
[Betablockers and the treatment of chronic heart failure].[β受体阻滞剂与慢性心力衰竭的治疗]
Medicina (B Aires). 1999;59(6):793-7.
10
Protocol Underemphasizes beta-blockers.方案对β受体阻滞剂重视不足。
J Am Pharm Assoc (Wash). 2001 Nov-Dec;41(6):793-4.
引用本文的文献
1
CaMKII and PKA-dependent phosphorylation co-regulate nuclear localization of HDAC4 in adult cardiomyocytes.钙调蛋白依赖性激酶 II 和蛋白激酶 A 依赖性磷酸化共同调节成年心肌细胞中组蛋白去乙酰化酶 4 的核定位。
Basic Res Cardiol. 2021 Feb 15;116(1):11. doi: 10.1007/s00395-021-00850-2.
2
Relationship between chronotropic incompetence and β-blockers based on changes in chronotropic response during cardiopulmonary exercise testing.基于心肺运动试验中心率反应变化探讨变时性功能不全与β受体阻滞剂之间的关系。
Int J Cardiol Heart Vasc. 2014 Dec 3;6:12-18. doi: 10.1016/j.ijcha.2014.11.002. eCollection 2015 Mar 1.
3
Pharmacological management of chronic heart failure in adults: a review of the literature.成人慢性心力衰竭的药物治疗：文献综述
Malawi Med J. 2004 Mar;16(1):22-6.
4
Beta-blockers for heart failure.用于治疗心力衰竭的β受体阻滞剂
Cochrane Database Syst Rev. 2000(2). doi: 10.1002/14651858.CD002131.
5
Chronic vagus nerve stimulation improves left ventricular function in a canine model of chronic mitral regurgitation.慢性迷走神经刺激可改善慢性二尖瓣反流犬模型的左心室功能。
J Transl Med. 2014 Nov 4;12:302. doi: 10.1186/s12967-014-0302-2.
6
Barriers to accurate diagnosis and effective management of heart failure have not changed in the past 10 years: a qualitative study and national survey.过去10年中，心力衰竭准确诊断和有效管理的障碍并未改变：一项定性研究和全国性调查。
BMJ Open. 2014 Apr 1;4(3):e003866. doi: 10.1136/bmjopen-2013-003866.
7
Vagus nerve stimulation improves left ventricular function in a canine model of chronic heart failure.迷走神经刺激改善慢性心力衰竭犬模型的左心室功能。
Eur J Heart Fail. 2013 Dec;15(12):1319-26. doi: 10.1093/eurjhf/hft118. Epub 2013 Jul 24.
8
Carvedilol in the treatment of elderly patients with chronic heart failure.卡维地洛治疗老年慢性心力衰竭患者
Clin Interv Aging. 2008;3(1):55-70. doi: 10.2147/cia.s1044.
9
The control of adrenergic function in heart failure: therapeutic intervention.心力衰竭中肾上腺素能功能的控制：治疗干预
Heart Fail Rev. 2000 Mar;5(1):101-14. doi: 10.1023/A:1009854325711.
10
Effect of a community heart failure clinic on uptake of beta blockers by patients with obstructive airways disease and heart failure.社区心力衰竭诊所对患有阻塞性气道疾病和心力衰竭患者使用β受体阻滞剂的影响。
Heart. 2006 Mar;92(3):331-6. doi: 10.1136/hrt.2004.059758. Epub 2005 Jun 10.
本文引用的文献
1
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.心脏不全比索洛尔研究II（CIBIS-II）：一项随机试验。
Lancet. 1999 Jan 2;353(9146):9-13.
2
Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials.β-肾上腺素能阻滞剂在慢性心力衰竭中的临床疗效：双盲、安慰剂对照、随机试验的荟萃分析
Circulation. 1998 Sep 22;98(12):1184-91. doi: 10.1161/01.cir.98.12.1184.
3
Successes and failures of current treatment of heart failure.当前心力衰竭治疗的成功与失败
Lancet. 1998 Aug;352 Suppl 1:SI19-28. doi: 10.1016/s0140-6736(98)90015-0.
4
Heart failure: a medical hydra.心力衰竭：一种医学上的多头怪物。
Lancet. 1998 Aug;352 Suppl 1:SI1-2. doi: 10.1016/s0140-6736(98)90011-3.
5
6
North of England evidence based development project: guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failure.英格兰北部循证发展项目：成人症状性心力衰竭初级护理管理中血管紧张素转换酶抑制剂指南
BMJ. 1998 May 2;316(7141):1369-75. doi: 10.1136/bmj.316.7141.1369.
7
Nebivolol in the treatment of cardiac failure: a double-blind controlled clinical trial.
J Card Fail. 1997 Dec;3(4):271-6. doi: 10.1016/s1071-9164(97)90026-9.
8
Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study.充血性心力衰竭患者联合使用血管紧张素转换酶抑制剂、血管紧张素 II 拮抗剂和β受体阻滞剂进行神经激素阻断治疗：左心室功能障碍策略随机评估（RESOLVD）初步研究的设计
Can J Cardiol. 1997 Dec;13(12):1166-74.
9
Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics plus angiotensin-converting enzyme inhibitors.在接受利尿剂加血管紧张素转换酶抑制剂治疗的既往有心肌梗死、充血性心力衰竭且左心室射血分数≥40%的老年患者中，普萘洛尔与未使用普萘洛尔对总死亡率加非致命性心肌梗死的影响。
Am J Cardiol. 1997 Jul 15;80(2):207-9. doi: 10.1016/s0002-9149(97)00320-2.
10
Bayesian approaches to random-effects meta-analysis: a comparative study.随机效应荟萃分析的贝叶斯方法：一项比较研究。
Stat Med. 1995 Dec 30;14(24):2685-99. doi: 10.1002/sim.4780142408.
Zotero 插件